Previous data have indicated that cytokines, such as IL2, IL6, TGF-β, and CXCL5, in an immune-reactive TME, may stimulate CD274 expression on tumor cells through distinct signaling, potentially representing one of the causes of immune tolerance [32–35]. This evidence concerns the gene CD274 and neoplasm.